IO Biotech, Inc. Quarterly Operating Income (Loss) in USD from Q3 2020 to Q4 2024
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
IO Biotech, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2020 to Q4 2024.
- IO Biotech, Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$26.9M, a 4.4% increase year-over-year.
- IO Biotech, Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$95.2M, a 4.08% decline year-over-year.
- IO Biotech, Inc. annual Operating Income (Loss) for 2024 was -$95.2M, a 4.08% decline from 2023.
- IO Biotech, Inc. annual Operating Income (Loss) for 2023 was -$91.4M, a 28% decline from 2022.
- IO Biotech, Inc. annual Operating Income (Loss) for 2022 was -$71.4M, a 73.2% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)